Operating Income for Align Technology (ALGN)
According to Align Technology's latest reported financial statements, the company's current operating income (TTM) is $550.02M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

ALGN
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$550.02M
YoY change
+1.4%
5Y CAGR
+9.7%
Peak year (2021)
$976.40M
Cumulative operating income
$5.94B
Operating Income history chart for Align Technology (ALGN) from 1999 to 2025
Operating Income history table for Align Technology (ALGN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $616.22M | +1.4% | ||
| 2024 | $607.63M | -5.6% | ||
| 2023 | $643.34M | +0.1% | ||
| 2022 | $642.60M | -34.2% | ||
| 2021 | $976.40M | +152.2% | ||
| 2020 | $387.17M | -28.6% | ||
| 2019 | $542.49M | +16.3% | ||
| 2018 | $466.56M | +31.9% | ||
| 2017 | $353.61M | +42.1% | ||
| 2016 | $248.92M | +32.0% | ||
| 2015 | $188.63M | -2.6% | ||
| 2014 | $193.58M | +105.5% | ||
| 2013 | $94.21M | +10.1% | ||
| 2012 | $85.59M | -5.3% | ||
| 2011 | $90.36M | -12.0% | ||
| 2010 | $102.73M | -402.1% | ||
| 2009 | -$34.01M | -319.2% | ||
| 2008 | $15.51M | -54.2% | ||
| 2007 | $33.85M | -190.2% | ||
| 2006 | -$37.54M | -1634.6% | ||
| 2005 | $2.45M | -75.0% | ||
| 2004 | $9.77M | -149.0% | ||
| 2003 | -$19.94M | -72.6% | ||
| 2002 | -$72.82M | -27.7% | ||
| 2001 | -$100.77M | +24.2% | ||
| 2000 | -$81.11M | +451.6% | ||
| 1999 | -$14.71M | — |
Operating Income values are taken from Align Technology's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Align Technology (ALGN) operating income is $616.22M – edged up 1.4% year-over-year.
Across 2020–2025 (5 years), Align Technology operating income produced a CAGR of +9.7% – with the latest reading among the more recent periods of the dataset.
Between 2021 and 2025, Align Technology operating income plunged 36.9%, falling from $976.40M to $616.22M.
Across the available history, operating income reached its high of $976.40M in 2021 and its low of -$100.77M in 2001.
Align Technology (ALGN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $22.84B.
Align Technology Operating Income by Year
Align Technology Operating Income 2025: $616.22M
Align Technology operating income in 2025 was $616.22M, edged up 1.4% from 2024.
Align Technology Operating Income 2024: $607.63M
Align Technology operating income in 2024 was $607.63M, declined 5.6% below 2023.
Align Technology Operating Income 2023: $643.34M
Align Technology operating income in 2023 was $643.34M, edged up 0.1% from 2022.
Align Technology Operating Income 2022: $642.60M
Align Technology operating income in 2022 was $642.60M, plunged 34.2% below 2021.
Align Technology Operating Income 2021: $976.40M
Align Technology operating income in 2021 was $976.40M.
See more financial history for Align Technology (ALGN).
Sector peers — Operating Income
Companies in the same sector as Align Technology, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Align Technology's operating income?
- Latest reported operating income for Align Technology (ALGN) is $550.02M (period ending December 31, 2025).
How has Align Technology operating income changed year-over-year?
- Align Technology (ALGN) operating income changed +1.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Align Technology operating income?
- Align Technology (ALGN) operating income compound annual growth rate is +9.7% over the most recent 5 years available.
When did Align Technology operating income hit its highest annual value?
- Align Technology operating income reached its highest annual value of $976.40M in 2021.
What was Align Technology operating income in 2024?
- Align Technology (ALGN) operating income in 2024 was $607.63M.
What was Align Technology operating income in 2025?
- Align Technology (ALGN) operating income in 2025 was $616.22M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ALGN Overview
Company profile, financial tools, and key metrics
ALGN Revenue Counter
Earns $127.95 every second. See per minute, hour, and day.
ALGN Earnings Counter
Earns $13.01 per second net profit. See per minute, hour, and day.
ALGN Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
ALGN What If Invested
What if you had invested $1,000? See historical returns from any date.
ALGN How It Makes Money
Discover visual breakdown of $4.03B in revenue — where it comes from and where it goes.
ALGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALGN Daily Price Character
Explosive · 49.8% historical win rate (green days). Streaks & record days.
ALGN Buybacks
3.49% TTM buyback yield. Shareholder yield & SBC comparison.